Bloodstream Infections Due to Carbapenem-resistant Enterobacteriaceae

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2018-10-16
Clinical Trial Update: A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE) [Phase 3]
Phase 3 trial comparing plazomicin to colistin in CRE infections completed with results posted in 2018.